<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="wagner" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">wagner</book-part-id>
      <title-group>
        <title>
<italic toggle="yes">VCAN</italic>-Related Vitreoretinopathy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kloeckener-Gruissem</surname>
            <given-names>Barbara</given-names>
          </name>
          <degrees>PhD</degrees>
          <email>kloeckener@medgen.uzh.ch</email>
          <aff>Institute of Medical Molecular Genetics <break/>University of Zurich and ETH Zurich<break/>Department of Biology <break/>ETH Zurich<break/>Zurich, Switzerland</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Amstutz</surname>
            <given-names>Christoph</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <email>christoph.amstutz@luks.ch</email>
          <aff>Luzerner Kantonsspital<break/>Lucerne, Switzerland</aff>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2009-02-03" date-type="created">
          <day>3</day>
          <month>2</month>
          <year>2009</year>
        </date>
        <date iso-8601-date="2016-01-07" date-type="updated">
          <day>7</day>
          <month>1</month>
          <year>2016</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="usher2" document-type="chapter">Usher Syndrome Type II</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="vldlr-ch" document-type="chapter"><italic toggle="yes">VLDLR</italic>-Associated Cerebellar Hypoplasia</related-object>
      <abstract id="wagner.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">VCAN</italic>-related vitreoretinopathy, which includes Wagner syndrome and erosive vitreoretinopathy (ERVR), is characterized by &#x0201c;optically empty vitreous&#x0201d; on slit-lamp examination and avascular vitreous strands and veils, mild or occasionally moderate to severe myopia, presenile cataract, night blindness of variable degree associated with progressive chorioretinal atrophy, retinal traction and retinal detachment in the advanced stages of disease, and reduced visual acuity. Optic nerve inversion as well as uveitis has also been described. Systemic abnormalities are not observed. The first signs usually become apparent during early adolescence, but onset can be as early as age two years.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of <italic toggle="yes">VCAN</italic>-related vitreoretinopathy is established in a proband with characteristic ocular findings and a family history consistent with autosomal dominant inheritance. Identification of a heterozygous <italic toggle="yes">VCAN</italic> pathogenic variant establishes the diagnosis if clinical features are inconclusive.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Refractive error is corrected by spectacles or contact lenses; visually disabling cataract is treated by cataract surgery, preferably by an experienced surgeon. Posterior capsule opacification is treated with YAG laser capsulotomy. Retinal breaks without retinal detachment are treated with laser retinopexy or cryocoagulation. Vitreoretinal surgery is indicated for retinal detachment, vitreoretinal traction involving the macula, or epiretinal membranes involving the macula.</p>
          <p><italic toggle="yes">Surveillance:</italic> Annual ophthalmologic examination by a vitreoretinal specialist.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> For the purpose of early diagnosis and treatment of ophthalmologic complications in at-risk relatives: molecular genetic testing if the pathogenic variant has been identified in the family; otherwise, ophthalmologic evaluation.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">VCAN</italic>-related vitreoretinopathy is inherited in an autosomal dominant manner. Most individuals diagnosed with <italic toggle="yes">VCAN</italic>-related vitreoretinopathy have an affected parent. Each child of an affected individual has a 50% chance of inheriting the pathogenic variant. Prenatal testing is possible for families in which the pathogenic variant is known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="wagner.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="wagner.Tc" position="anchor" orientation="portrait">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_wagner.Tc_1_1_1_1" valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">VCAN-</italic>Related Vitreoretinopathy: Included Phenotypes</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_wagner.Tc_1_1_1_1" valign="top" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Wagner vitreoretinal degeneration (Wagner syndrome)</p>
                    </list-item>
                    <list-item>
                      <p>Erosive vitreoretinopathy (ERVR)</p>
                    </list-item>
                  </list>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="wagner.Nomenclature">Nomenclature</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="wagner.Diagnosis">
        <title>Diagnosis</title>
        <sec id="wagner.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p><italic toggle="yes">VCAN</italic>-related vitreoretinopathy <bold>should be suspected</bold> in individuals with the following characteristic features:</p>
          <list list-type="bullet">
            <list-item>
              <p>&#x0201c;Optically empty vitreous&#x0201d; on slit-lamp examination and avascular vitreous strands and veils</p>
            </list-item>
            <list-item>
              <p>Mild or occasionally moderate to severe myopia</p>
            </list-item>
            <list-item>
              <p>Presenile cataract</p>
            </list-item>
            <list-item>
              <p>Night blindness of variable degree associated with progressive chorioretinal atrophy</p>
            </list-item>
            <list-item>
              <p>Retinal traction and detachment at advanced stages of the disease</p>
            </list-item>
            <list-item>
              <p>Reduced visual acuity resulting from the above manifestations</p>
            </list-item>
            <list-item>
              <p>Uveitis</p>
            </list-item>
            <list-item>
              <p>Absence of systemic abnormalities</p>
            </list-item>
          </list>
        </sec>
        <sec id="wagner.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of <italic toggle="yes">VCAN</italic>-related vitreoretinopathy <bold>is established</bold> in a proband with the above clinical findings and a family history consistent with autosomal dominant inheritance. Not every clinical finding listed above is observed in every affected individual. The hallmark, however, is the empty vitreous. Establishing the diagnosis may be more difficult in a simplex case (i.e., a single occurrence in a family). Identification of a heterozygous pathogenic variant in <italic toggle="yes">VCAN</italic> by molecular genetic testing (see <xref ref-type="table" rid="wagner.T.molecular_genetic_testing_used">Table 1</xref>) establishes the diagnosis if clinical features are inconclusive.</p>
          <p>Molecular testing approaches can include <bold>single-gene testing</bold> and use of a <bold>multi-gene panel.</bold></p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> All <italic toggle="yes">VCAN</italic> pathogenic variants associated with Wagner syndrome and erosive vitreoretinopathy found to date have been in the splice acceptor or splice donor site of introns 7 and 8; sequence analysis of this DNA region is recommended as a first step. If targeted testing is not available, sequence analysis of <italic toggle="yes">VCAN</italic> should be done.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">VCAN</italic> and other genes of interest (see <xref ref-type="sec" rid="wagner.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note (1): The genes included and sensitivity of multi-gene panels vary by laboratory and over time. (2) The presence of characteristic connective tissue abnormalities in the proband or relatives could prompt genetic testing for <related-object link-type="booklink" source-id="gene" document-id="stickler" document-type="chapter">Stickler syndrome</related-object> rather than or in addition to sequence analysis of <italic toggle="yes">VCAN</italic>.</p>
            </list-item>
          </list>
          <table-wrap id="wagner.T.molecular_genetic_testing_used" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in <italic toggle="yes">VCAN</italic>-Related Vitreoretinopathy</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_wagner.T.molecular_genetic_testing_used_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_wagner.T.molecular_genetic_testing_used_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_wagner.T.molecular_genetic_testing_used_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_wagner.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">VCAN</italic>
                  </td>
                  <td headers="hd_h_wagner.T.molecular_genetic_testing_used_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup><hr/></td>
                  <td headers="hd_h_wagner.T.molecular_genetic_testing_used_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">18/20 families with <italic toggle="yes">VCAN</italic>-related vitreoretinopathy&#x000a0;<sup>4</sup><hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_wagner.T.molecular_genetic_testing_used_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_wagner.T.molecular_genetic_testing_used_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>6</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="wagner.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="wagner" object-id="wagner.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="wagner.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="wagner.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="wagner.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="wagner.TF.1.4">
                <label>4. </label>
                <p>In 18 of 20 families with <italic toggle="yes">VCAN</italic>-related vitreoretinopathy, sequence analysis of the entire <italic toggle="yes">VCAN</italic> coding region and flanking introns identified pathogenic variants; in two families no pathogenic variant was found (see references in <xref ref-type="table" rid="wagner.T.selected_vcan_pathogenic_varian">Table 2</xref>).</p>
              </fn>
              <fn id="wagner.TF.1.5">
                <label>5. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="wagner.TF.1.6">
                <label>6. </label>
                <p>No data on detection rate of gene-targeted deletion/duplication analysis are available.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="wagner.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="wagner.Clinical_Description">
          <title>Clinical Description</title>
          <p><italic toggle="yes">VCAN</italic>-related vitreoretinopathy comprises the phenotypic continuum of Wagner vitreoretinal degeneration (Wagner syndrome) and erosive vitreoretinopathy (ERVR).</p>
          <p><bold>Vitreoretinal degeneration.</bold> The hallmark of <italic toggle="yes">VCAN</italic>-related vitreoretinopathy is progressive degenerative changes of the vitreous (syneresis) and the vitreoretinal interface beginning at a young age. Syneresis can lead to massive liquefaction of the vitreous such that on slit-lamp examination the vitreous cavity appears optically empty ("empty vitreous") with pockets of liquefied vitreous that are usually lined by avascular strands and veils. Preretinal vitreous membranes that span the whole equator of the eye are characteristic. Ocular changes show considerable inter- and intrafamilial variability.</p>
          <p>The first signs usually become apparent during early adolescence, but onset can be as early as age two years [<xref ref-type="bibr" rid="wagner.REF.miyamoto.2005.2726">Miyamoto et al 2005</xref>].</p>
          <p>No gender-specific difference in the occurrence or frequency of any particular ocular features has been observed.</p>
          <p>The vitreous degeneration, which is assumed to be the primary pathology, leads to a number of secondary changes, including presenile cataract, degeneration and atrophy of the retina and the underlying retinal pigment epithelium (RPE) and choroid, and retinal detachment [<xref ref-type="bibr" rid="wagner.REF.wagner.1938.840">Wagner 1938</xref>, <xref ref-type="bibr" rid="wagner.REF.jansen.1962.458">Jansen 1962</xref>, <xref ref-type="bibr" rid="wagner.REF.graemiger.1995.1830">Graemiger et al 1995</xref>, <xref ref-type="bibr" rid="wagner.REF.zech.1999.387">Zech et al 1999</xref>, <xref ref-type="bibr" rid="wagner.REF.miyamoto.2005.2726">Miyamoto et al 2005</xref>, <xref ref-type="bibr" rid="wagner.REF.mukhopadhyay.2006.3565">Mukhopadhyay et al 2006</xref>, <xref ref-type="bibr" rid="wagner.REF.meredith.2007.655">Meredith et al 2007</xref>].</p>
          <sec id="wagner.Common_Ocular_Features__60_of_Aff">
            <title>Common Ocular Features (&#x02264;60% of Affected Individuals)</title>
            <p><bold>Myopic refractive error</bold> (nearsightedness) results from axial myopia (a developmental mismatch of the refractive power and length of the globe) and/or index myopia (a change in the refractive index of the progressively cataractous lens). Axial myopia is common, although severity varies. In the family reported by Wagner, most affected members had mild myopia and only a few had moderate to severe myopia. In contrast, in the Dutch family all members had high myopia with astigmatism [<xref ref-type="bibr" rid="wagner.REF.jansen.1962.458">Jansen 1962</xref>].</p>
            <p><bold>Presenile cataract</bold> (progressive loss of transparency of the ocular lens) is a common finding and a common cause of decline in visual acuity over time. The types of cataract vary. Small spherical opacities and posterior subcapsular cataract affected 43% of eyes in the original family reported by Wagner [<xref ref-type="bibr" rid="wagner.REF.graemiger.1995.1830">Graemiger et al 1995</xref>]. In the Dutch families, cataract types included moderate cortical cataract, anterior and posterior cortical cataract, and posterior subcapsular cataract [<xref ref-type="bibr" rid="wagner.REF.mukhopadhyay.2006.3565">Mukhopadhyay et al 2006</xref>]. Nuclear cataract without any posterior subcapsular opacity was described in a British family [<xref ref-type="bibr" rid="wagner.REF.meredith.2007.655">Meredith et al 2007</xref>].</p>
            <p>In a Japanese family, approximately 50% of affected individuals underwent cataract surgery; the oldest was age 35 years [<xref ref-type="bibr" rid="wagner.REF.miyamoto.2005.2726">Miyamoto et al 2005</xref>]. In a French family, cataract affected 55% of individuals [<xref ref-type="bibr" rid="wagner.REF.zech.1999.387">Zech et al 1999</xref>]. Of note, even after cataract extraction and correction of the refractive error, visual acuity was not normal, typically ranging from 6/12 (20/40) to 6/24 (20/80).</p>
            <p><bold>Nonspecific reactive changes of the retinal pigment epithelium and overlying retina</bold> (pigment condensation, vascular sheathing, pigmented lattice degeneration, and later chorioretinal atrophy in the retinal periphery) occur. Affected individuals may experience nyctalopia (night blindness) and visual field constriction that are not as severe as those seen in <related-object link-type="booklink" source-id="gene" document-id="rp-overview" document-type="chapter">retinitis pigmentosa</related-object>. Nyctalopia may or may not progress. In some individuals the chorioretinal atrophy is so severe that it resembles <related-object link-type="booklink" source-id="gene" document-id="choroid" document-type="chapter">choroideremia</related-object>. Diffuse retinal pigmentary changes and patchy chorioretinal atrophy are observed in some (but not all) family members affected by Wagner syndrome [<xref ref-type="bibr" rid="wagner.REF.meredith.2007.655">Meredith et al 2007</xref>, <xref ref-type="bibr" rid="wagner.REF.ronan.2009.1511">Ronan et al 2009</xref>].</p>
            <p>The full-field electroretinogram (ERG) becomes attenuated. Typically both the amplitudes of the a-waves (response of the photoreceptor layer) and the b-waves (response of the bipolar cell layer) are reduced. The rod and cone systems (as measured by the scotopic and photopic response, respectively) are affected to varying degrees but in a family-specific manner, as demonstrated by the Swiss family originally reported by Wagner, the Japanese family, and the British family [<xref ref-type="bibr" rid="wagner.REF.graemiger.1995.1830">Graemiger et al 1995</xref>, <xref ref-type="bibr" rid="wagner.REF.miyamoto.2005.2726">Miyamoto et al 2005</xref>, <xref ref-type="bibr" rid="wagner.REF.meredith.2007.655">Meredith et al 2007</xref>].</p>
            <p><bold>Abnormal retinal vessels or poor vascularization of the peripheral retina</bold> were found in approximately 50% of individuals from the family reported by Wagner [<xref ref-type="bibr" rid="wagner.REF.graemiger.1995.1830">Graemiger et al 1995</xref>], but only in a few individuals of the Dutch families [<xref ref-type="bibr" rid="wagner.REF.mukhopadhyay.2006.3565">Mukhopadhyay et al 2006</xref>].</p>
            <p><bold>Retinal detachment</bold> was initially found to be associated with increasing age; however, a later report indicated that detachments can occur earlier (average age 9.5 years) [<xref ref-type="bibr" rid="wagner.REF.ronan.2009.1511">Ronan et al 2009</xref>]. Caused by shrinkage of the preretinal membranes and the vitreous strands and veils, retinal detachment is either tractional or rhegmatogenous.</p>
            <list list-type="bullet">
              <list-item>
                <p>Tractional retinal detachment is caused by tangential shortening of the adhering membranes. The detached retina is rigid; successful surgical repair requires meticulous removal of the membranes and vitreoretinal adhesions and, most often, extensive retinotomies to relieve the traction. Tractional retinal detachment is not a particularly common feature of Wagner syndrome.</p>
              </list-item>
              <list-item>
                <p>Rhegmatogenous retinal detachment is caused by retinal breaks associated with the preretinal membranes. Liquefied vitreous fluid enters the potential subretinal space through one or more retinal tears caused by shrinking membranes. The retinal detachment is typically bullous; surgical repair primarily relies on closure of all retinal breaks. Of note, in a considerable number of young individuals rhegmatogenous retinal detachment associated with hereditary vitreoretinal degeneration presents with only minor changes of the vitreous. Consequently, large retinal tears in young persons should raise the suspicion of a hereditary disease, and should prompt examination of other family members and eventually molecular genetic analysis.</p>
              </list-item>
            </list>
            <p>In the original publication by Wagner the incidence of retinal detachment at age 20 years was one in four, whereas in the Dutch pedigrees published by Jansen bilateral retinal detachment was a frequent finding at a young age. Of note, follow-up publications of the original Wagner pedigree reported an incidence of retinal detachment of greater than one in two. Of the few retinal detachments described in the Swiss family reported originally by Wagner and in the Dutch families reported by Jansen, some were peripheral tractional [<xref ref-type="bibr" rid="wagner.REF.graemiger.1995.1830">Graemiger et al 1995</xref>, <xref ref-type="bibr" rid="wagner.REF.mukhopadhyay.2006.3565">Mukhopadhyay et al 2006</xref>]. Further tractional effects were observed as situs inversus [<xref ref-type="bibr" rid="wagner.REF.wagner.1938.840">Wagner 1938</xref>]. Recently, affected individuals were described with inversion of the papilla as a possible consequence of tractional forces [<xref ref-type="bibr" rid="wagner.REF.ronan.2009.1511">Ronan et al 2009</xref>].</p>
            <p>In the Japanese family reported by <xref ref-type="bibr" rid="wagner.REF.miyamoto.2005.2726">Miyamoto et al [2005]</xref>, most of the retinal detachments were rhegmatogenous. No retinal detachments were observed in the only two affected individuals reported in a British family [<xref ref-type="bibr" rid="wagner.REF.meredith.2007.655">Meredith et al 2007</xref>].</p>
          </sec>
          <sec id="wagner.Occasional_Ocular_Features">
            <title>Occasional Ocular Features</title>
            <p>The following features have been reported rarely. Some may not be part of <italic toggle="yes">VCAN</italic>-related vitreoretinopathy but rather occur coincidentally.</p>
            <p><bold>Spherophakia</bold>, a spherical deformation of the ocular lens, has been observed sporadically in persons with <italic toggle="yes">VCAN</italic>-related vitreoretinopathy [<xref ref-type="bibr" rid="wagner.REF.graemiger.1995.1830">Graemiger et al 1995</xref>].</p>
            <p><bold>Cataract</bold> can induce a change of the refractive index of the lens nucleus, further attenuating the myopic refractive error (index myopia).</p>
            <p><bold>Posterior vitreous detachment</bold> (PVD), detachment of the posterior vitreous membrane from the retinal surface, is caused by shrinkage of the vitreous body and the pathologic vitreoretinal interface. In contrast to the usual age-related PVD, the PVD in <italic toggle="yes">VCAN</italic>-related vitreoretinopathy initially affects the peripheral rather than the central posterior vitreous. None of the individuals from the original family described by Wagner or the French family showed PVD [<xref ref-type="bibr" rid="wagner.REF.graemiger.1995.1830">Graemiger et al 1995</xref>, <xref ref-type="bibr" rid="wagner.REF.zech.1999.387">Zech et al 1999</xref>].</p>
            <p><bold>Ectopic fovea</bold>, manifesting as an increased angle kappa (the angle between the visual axis and the pupillary axis), has occasionally been reported [<xref ref-type="bibr" rid="wagner.REF.graemiger.1995.1830">Graemiger et al 1995</xref>, <xref ref-type="bibr" rid="wagner.REF.miyamoto.2005.2726">Miyamoto et al 2005</xref>, <xref ref-type="bibr" rid="wagner.REF.meredith.2007.655">Meredith et al 2007</xref>].</p>
            <p><bold>Phthisis bulbi</bold> (painful shrinking of the ocular globe as a result of loss of intraocular pressure) can occur and may require enucleation of the eye. Retinal detachment that has not been repaired successfully and retinal detachment associated with proliferative retinal vitreoretinopathy (PVR) are risk factors for phthisis bulbi. The decrease in intraocular pressure is caused by decreased aqueous production by the ciliary body epithelium, which becomes compromised by the pathologic vitreoretinal membranes because of the primary vitreal changes, the PVR, or both.</p>
            <p><bold>Synchysis scintillans</bold> (bilateral accumulation of cholesterol crystals in the vitreous, which may or may not be associated with recurrent vitreous hemorrhage), may or may not occur with increased frequency in <italic toggle="yes">VCAN</italic>-related vitreoretinopathy, as it was only observed in a few older affected individuals [<xref ref-type="bibr" rid="wagner.REF.graemiger.1995.1830">Graemiger et al 1995</xref>, <xref ref-type="bibr" rid="wagner.REF.zech.1999.387">Zech et al 1999</xref>].</p>
            <p><bold>Optic atrophy</bold> was found in only a few of the older individuals from the original Wagner family. These individuals had advanced chorioretinal atrophy, suggesting that optic atrophy is secondary to the massive loss in retinal ganglion cells [<xref ref-type="bibr" rid="wagner.REF.graemiger.1995.1830">Graemiger et al 1995</xref>].</p>
            <p><bold>Glaucoma</bold> may be an occasional feature of Wagner syndrome, or a sequela of the disease such as aphakia glaucoma or rubeotic glaucoma. In the original pedigree, ten individuals out of the sixty family members exhibited a dysgenetic chamber angle [<xref ref-type="bibr" rid="wagner.REF.graemiger.1995.1830">Graemiger et al 1995</xref>]; one individual had congenital glaucoma. Three individuals with congenital glaucoma were reported by <xref ref-type="bibr" rid="wagner.REF.jewsbury.2014.291">Jewsbury et al [2014]</xref>.</p>
            <p><bold>Exudative vitreoretinopathy</bold> with vascular abnormalities has been reported in one French family [<xref ref-type="bibr" rid="wagner.REF.br_zin.2011.1669">Br&#x000e9;zin et al 2011</xref>]; in fact, <related-object link-type="booklink" source-id="gene" document-id="fevr" document-type="chapter">familial exudative vitreoretinopathy</related-object> (FEVR) was the initial diagnosis suspected in this family.</p>
            <p><bold>Uveitis</bold> is a rare clinical feature of <italic toggle="yes">VCAN</italic>-related vitreoretinopathy that has come to attention only recently. Uveitis was reported in a French [<xref ref-type="bibr" rid="wagner.REF.br_zin.2011.1669">Br&#x000e9;zin et al 2011</xref>] and a British [<xref ref-type="bibr" rid="wagner.REF.meredith.2007.655">Meredith et al 2007</xref>] family as spontaneous anterior uveitis, and otherwise unexplained severe and prolonged intraocular inflammation after uneventful cataract surgery, respectively [<xref ref-type="bibr" rid="wagner.REF.rothschild.2011.1555">Rothschild et al 2011</xref>, <xref ref-type="bibr" rid="wagner.REF.rothschild.2013b.2040">Rothschild et al 2013b</xref>]. Given versican's role in inflammation and cancer that was increasingly elucidated during the last decade, the occurrence of uveitis in individuals with <italic toggle="yes">VCAN</italic>-related vitreoretinopathy is likely related to the causative genetic defect [<xref ref-type="bibr" rid="wagner.REF.du.2013.701">Du et al 2013</xref>, <xref ref-type="bibr" rid="wagner.REF.wight.2014.152">Wight et al 2014</xref>].</p>
            <p><bold>Systemic findings.</bold> No systemic abnormalities associated with <italic toggle="yes">VCAN</italic>-related vitreoretinopathy have been reported to date, and consequently <italic toggle="yes">VCAN</italic>-related vitreoretinopathy is considered an isolated vitreoretinal degeneration.</p>
          </sec>
        </sec>
        <sec id="wagner.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Because of the highly variable frequency of findings and the low number of pathogenic variants identified to date, no definite genotype-phenotype correlations have been established.</p>
        </sec>
        <sec id="wagner.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance appears to be complete. Within families reported to date, no unaffected individuals had a <italic toggle="yes">VCAN</italic> pathogenic variant.</p>
        </sec>
        <sec id="wagner.Nomenclature">
          <title>Nomenclature</title>
          <p>Some authors have referred to <related-object link-type="booklink" source-id="gene" document-id="stickler" document-type="chapter">Stickler syndrome</related-object> associated with pathogenic variants in exon 2 of <italic toggle="yes">COL2A1</italic> as Wagner syndrome type II. The <italic toggle="yes">VCAN</italic>-related phenotype has been referred to as vitreoretinochoroidopathy (VRCP) Wagner syndrome type I [<xref ref-type="bibr" rid="wagner.REF.gupta.2002.203">Gupta et al 2002</xref>] or hyaloideoretinal degeneration of Wagner.</p>
        </sec>
        <sec id="wagner.Prevalence">
          <title>Prevalence</title>
          <p>Wagner syndrome is a very rare disorder. After the first Swiss pedigree reported by <xref ref-type="bibr" rid="wagner.REF.wagner.1938.840">Wagner [1938]</xref>, several additional families (some of them very large) have been reported. Including families with ERVR, not more than 50 families or simplex cases of <italic toggle="yes">VCAN</italic>-related vitreoretinopathy have been reported.</p>
          <p>Wagner syndrome has been reported in families of various ethnic backgrounds including northern European, Japanese, and Chinese.</p>
        </sec>
      </sec>
      <sec id="wagner.Genetically_Related_Allelic_Disor">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with pathogenic variants in <italic toggle="yes">VCAN</italic>.</p>
      </sec>
      <sec id="wagner.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Syndromes with overlapping features.</bold> A review by <xref ref-type="bibr" rid="wagner.REF.edwards.2008.460">Edwards [2008]</xref> summarizes the clinical features of inherited vitreoretinopathies and points out the importance of consulting an expert ophthalmologist in diagnostic assessment of the disease.</p>
        <sec id="wagner.Autosomal_Dominant_Vitreoretinopa">
          <title>Autosomal Dominant Vitreoretinopathies</title>
          <p><bold>Snowflake vitreoretinal degeneration (SVD)</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/193230">OMIM 193230</ext-link>). SVD is caused by pathogenic variants in <italic toggle="yes">KCNJ13</italic>.</p>
          <list list-type="bullet">
            <list-item>
              <p>Both SVD and <italic toggle="yes">VCAN</italic>-related vitreoretinopathy exhibit vitreous abnormalities including fibrillar condensation, gel liquefaction, and marked thickening of the cortical vitreous.</p>
            </list-item>
            <list-item>
              <p>In SVD, however, membranous degeneration of the vitreous with avascular strands and veils is not observed. Retinal defects start in the superficial retinal layers, whereas in <italic toggle="yes">VCAN</italic>-related vitreoretinopathy they start in the deep retinal layers and choroid; retinal detachment is uncommon; and the retinal crystalline snowflake-like deposits that give the disease its name are common.</p>
            </list-item>
            <list-item>
              <p><related-object link-type="booklink" source-id="gene" document-id="stickler" document-type="chapter">Stickler syndrome</related-object>, or hereditary arthroophthalmopathy, is a connective tissue disorder that can include ocular findings of myopia, cataract, and retinal detachment; hearing loss that is both conductive and sensorineural; midfacial underdevelopment and cleft palate (either alone or as part of the Robin sequence); and mild spondyloepiphyseal dysplasia and/or precocious arthritis. Variable phenotypic expression of Stickler syndrome occurs both within and among families; interfamilial variability is in part explained by locus and allelic heterogeneity. Stickler syndrome caused by mutation of <italic toggle="yes">COL2A1</italic>, <italic toggle="yes">COL11A1</italic>, or <italic toggle="yes">COL11A2</italic> is inherited in an autosomal dominant manner.</p>
            </list-item>
            <list-item>
              <p>Retinal detachment is much more common in Stickler syndrome (50%) than in <italic toggle="yes">VCAN</italic>-related vitreoretinopathy (15%).</p>
            </list-item>
            <list-item>
              <p>Abnormal dark adaptation associated with alterations in the electroretinogram (ERG) that is common in <italic toggle="yes">VCAN</italic>-related vitreoretinopathy has not been described in Stickler syndrome.</p>
            </list-item>
            <list-item>
              <p>Type 1 Stickler syndrome (in which individuals have the membranous type of vitreous abnormality) is caused by pathogenic variants in <italic toggle="yes">COL2A1</italic> encoding collagen alpha-1(II) chain. Certain pathogenic variants in <italic toggle="yes">COL2A1</italic> cause a predominantly ocular or nonsyndromic phenotype which can be readily distinguished from Wagner syndrome by the specific vitreous anomaly associated with type 1 Stickler syndrome. However, some authors have referred to this form of Stickler syndrome as Wagner syndrome type II [<xref ref-type="bibr" rid="wagner.REF.gupta.2002.203">Gupta et al 2002</xref>].</p>
            </list-item>
          </list>
          <p><bold>Autosomal dominant vitreoretinochoroidopathy (ADVIRC)</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/193220">OMIM 193220</ext-link>). Pathogenic variants in <italic toggle="yes">BEST1</italic>, the gene encoding bestrophin-1, are causative. Only a few families with vitreoretinochoroidopathy (VRCP) have been described. High myopia and retinal detachment do not appear to be part of VRCP [<xref ref-type="bibr" rid="wagner.REF.oh.2006.940">Oh &#x00026; Vallar 2006</xref>]. Affected individuals show the following findings that seem to progress more slowly than those of <italic toggle="yes">VCAN</italic>-related vitreoretinopathy:</p>
          <list list-type="bullet">
            <list-item>
              <p>Fibrillar condensation of the vitreous, but not optically empty vitreous</p>
            </list-item>
            <list-item>
              <p>Chorioretinal hyperpigmentation with peripheral pigmentary clumping</p>
            </list-item>
            <list-item>
              <p>Macular atrophy</p>
            </list-item>
            <list-item>
              <p>Breakdown of the blood retinal barrier (observed in one family)</p>
            </list-item>
            <list-item>
              <p>Normal full-field (Ganzfeld) ERG but altered multifocal ERG pattern</p>
            </list-item>
            <list-item>
              <p>Cataract</p>
            </list-item>
          </list>
          <p><bold>Autosomal dominant neovascular inflammatory vitreoretinopathy (ADNIV)</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/193235">OMIM 193235</ext-link>)<bold>.</bold> Pathogenic variants in <italic toggle="yes">CAPN5</italic> are causative [<xref ref-type="bibr" rid="wagner.REF.mahajan.2012.e1003001">Mahajan et al 2012</xref>]. <xref ref-type="bibr" rid="wagner.REF.bennett.1990.1125">Bennett et al [1990]</xref> reported a six-generation family with an autosomal dominant vitreoretinopathy in which the prevailing clinical features were severe anterior and posterior segment inflammation, neovascular proliferations and related complications (in particular tractional retinal detachment and neovascular glaucoma), and a selective loss of the b-wave amplitude on the ERG early in the disease.</p>
        </sec>
        <sec id="wagner.Autosomal_Recessive_Vitreoretinop">
          <title>Autosomal Recessive Vitreoretinopathies</title>
          <p><bold>Goldmann-Favre syndrome (included in enhanced S-cone syndrome)</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/268100">OMIM 268100</ext-link>)<bold>.</bold> Pathogenic variants in <italic toggle="yes">NR2E3</italic> (photoreceptor-specific nuclear receptor) have been identified in Goldmann-Favre syndrome, enhanced S-cone syndrome (ESCS), and clumped pigmentary retinal degeneration [<xref ref-type="bibr" rid="wagner.REF.haider.2000.127">Haider et al 2000</xref>]. These clinical entities are usually associated with night blindness and visual field constriction. Electroretinography characteristically reveals a severe reduction in rod function and a relatively enhanced function of the short-wavelength-sensitive cones.</p>
          <list list-type="bullet">
            <list-item>
              <p>The classic Goldmann-Favre phenotype includes progressive vitreous changes (vitreous liquefaction and fibrillar strands and veils); night blindness and severe reduction in the ERG in early childhood; chorioretinal atrophy and pigmentary retinal degeneration later in the disease course resulting in marked visual field loss; retinoschisis in the periphery, macula, or both; presenile cataract; and a hyperopic rather than myopic refractive error.</p>
            </list-item>
            <list-item>
              <p>Although ESCS lacks the marked vitreous changes typical of the Goldmann-Favre phenotype, vitreous cells are a very common feature, and more prominent vitreous changes including vitreous opacities, haze, and veils can occur. Peripheral retinoschisis has been observed in ESCS, and foveal schisis, eventually associated with cystoid changes, may even be a common feature. The fundus appearance varies, and features are overlapping with clumped pigmentary retinal degeneration, in which the retinal pigmentary changes are the most prominent feature of the phenotype [<xref ref-type="bibr" rid="wagner.REF.audo.2008.2082">Audo et al 2008</xref>].</p>
            </list-item>
          </list>
          <p><bold>Knobloch syndrome</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/267750">OMIM 267750</ext-link>). Knobloch syndrome is a syndromic vitreoretinopathy in which ocular changes similar to those of <italic toggle="yes">VCAN</italic>-related vitreoretinopathy are associated with occipital encephalocele. Pathogenic variants in <italic toggle="yes">COL18A1</italic> (encoding collagen, type XVIII, alpha 1) are causative [<xref ref-type="bibr" rid="wagner.REF.menzel.2004.77">Menzel et al 2004</xref>, <xref ref-type="bibr" rid="wagner.REF.keren.2007.1514">Keren et al 2007</xref>].</p>
        </sec>
      </sec>
      <sec id="wagner.Management">
        <title>Management</title>
        <sec id="wagner.Evaluations_Following_Initial_Dia">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with <italic toggle="yes">VCAN</italic>-related vitreoretinopathy, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Baseline ophthalmologic examination including best corrected visual acuity, assessment of intraocular pressure, slit-lamp examination of the anterior segment, and biomicroscopy and indirect ophthalmoscopy of the posterior segment</p>
            </list-item>
            <list-item>
              <p>Visual field examination</p>
            </list-item>
            <list-item>
              <p>Photographic fundus documentation</p>
            </list-item>
            <list-item>
              <p>Optical coherence tomography (OCT), if available. While not mandatory, OCT scan is useful to assess the vitreoretinal interface, quantify atrophic changes of the central retina, and evaluate for cystoid macular edema.</p>
            </list-item>
            <list-item>
              <p>Electroretinogram</p>
            </list-item>
            <list-item>
              <p>Orthoptic assessment</p>
            </list-item>
            <list-item>
              <p>Consultation with a medical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="wagner.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Refractive error</bold> is corrected by spectacles or contact lenses.</p>
          <p><bold>Visually disabling cataract</bold> is treated by cataract surgery. Phacoemulsification and implantation of an intraocular lens in the capsular bag has become the widely adopted standard procedure; however, as emphasized by Edwards, cataract surgery in individuals with vitreoretinopathy and possibly preceding vitrectomy can be difficult and should be performed by an experienced surgeon [<xref ref-type="bibr" rid="wagner.REF.miyamoto.2005.2726">Miyamoto et al 2005</xref>, <xref ref-type="bibr" rid="wagner.REF.edwards.2008.460">Edwards 2008</xref>].</p>
          <p><bold>Posterior capsule opacification</bold> after cataract surgery is treated with YAG laser capsulotomy.</p>
          <p><bold>Retinal breaks</bold> are treated with laser retinopexy or cryocoagulation if no retinal detachment is present.</p>
          <p><bold>Vitreoretinal surgery</bold> is indicated for retinal detachment, vitreoretinal traction involving the macula, or epiretinal membranes involving the macula.</p>
        </sec>
        <sec id="wagner.Surveillance">
          <title>Surveillance</title>
          <p>Annual ophthalmologic examination by a vitreoretinal specialist is indicated.</p>
        </sec>
        <sec id="wagner.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to evaluate apparently asymptomatic at-risk relatives of an affected individual in order to reduce morbidity by early diagnosis and treatment of ophthalmologic complications.</p>
          <p>Evaluations can include:</p>
          <list list-type="bullet">
            <list-item>
              <p>Molecular genetic testing if the pathogenic variant in the family is known.</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic exam if the pathogenic variant in the family is not known</p>
            </list-item>
          </list>
          <p>See <xref ref-type="sec" rid="wagner.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="wagner.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ClinicalTrials.gov">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="wagner.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="wagner.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">VCAN</italic>-related vitreoretinopathy is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="wagner.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Most individuals diagnosed with <italic toggle="yes">VCAN</italic>-related vitreoretinopathy have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with <italic toggle="yes">VCAN</italic>-related vitreoretinopathy may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. The proportion of cases caused by a <italic toggle="yes">de novo</italic> pathogenic variant is not known.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include ophthalmologic evaluation and/or molecular genetic testing of both parents.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, possible explanations include a <italic toggle="yes">de novo</italic> pathogenic variant in the proband or germline mosaicism in a parent (although no instances of germline mosaicism have been reported, it remains a possibility).</p>
            </list-item>
            <list-item>
              <p>The family history of some individuals diagnosed with <italic toggle="yes">VCAN</italic>-related vitreoretinopathy may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the affected parent. Therefore, an apparently negative family history cannot be confirmed unless appropriate evaluations (e.g., ophthalmologic exam and/or molecular genetic testing) have been performed on the parents of the proband.</p>
            </list-item>
            <list-item>
              <p>Note: If the parent is the individual in whom the pathogenic variant first occurred, s/he may have somatic mosaicism for the variant and may be mildly/minimally affected.</p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband.</bold> The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents:</p>
          <list list-type="bullet">
            <list-item>
              <p>If a parent of the proband has <italic toggle="yes">VCAN</italic>-related vitreoretinopathy, the risk to the sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">VCAN</italic> pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with <italic toggle="yes">VCAN</italic>-related vitreoretinopathy has a 50% chance of inheriting the pathogenic variant.</p>
          <p><bold>Other family members of a proband.</bold> The risk to other family members depends on the status of the proband's parents: if a parent is affected, his or her family members may be at risk.</p>
        </sec>
        <sec id="wagner.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="wagner.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <italic toggle="yes">de novo</italic>. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="wagner.Prenatal_Testing_and_Preimplantat">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">VCAN</italic> pathogenic variant has been identified in an affected family member, prenatal testing or preimplantation genetic diagnosis for a pregnancy at increased risk for <italic toggle="yes">VCAN</italic>-related vitreoretinopathy may be an option that a couple may wish to consider.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="wagner.Resources">
        <title>Resources</title>
      </sec>
      <sec id="wagner.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="wagner.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Since <italic toggle="yes">VCAN</italic> is expressed in many human tissues, pathogenic variants in <italic toggle="yes">VCAN</italic> could be expected to interfere with functions in tissues and organs other than the eye; the cardiovascular system in particular would seem a likely candidate, as versican, the protein product of <italic toggle="yes">VCAN</italic>, is a component of the extracellular matrix of the blood vessels [<xref ref-type="bibr" rid="wagner.REF.yao.1994.213">Yao et al 1994</xref>, <xref ref-type="bibr" rid="wagner.REF.lemire.1999.1630">Lemire et al 1999</xref>]. A possible explanation for the absence of consequences of <italic toggle="yes">VCAN</italic> pathogenic variants in nonocular tissues is that splicing of the <italic toggle="yes">VCAN</italic> transcripts may be tissue specific.</p>
          <p><bold>Gene structure.</bold> The genomic region (109,399 nucleotides) of <italic toggle="yes">VCAN</italic> includes 15 exons (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_004385.4">NM_004385.4</ext-link>, splice variant V0). The two largest exons, 7 (2961 nucleotides) and 8 (5262 nucleotides), are subject to alternative splicing, yielding four naturally occurring splice variants (named V0, 1, 2, and 3; see <xref ref-type="fig" rid="wagner.F1">Figure 1</xref>) that exhibit a tissue-specific expression pattern. The respective exon-intron boundaries show the consensus sequences for splice acceptor and splice donor sites. For a detailed summary of gene, splice variants, and protein information, see <related-object source-id="gene" document-id="wagner" object-id="wagner.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Pathogenic allelic variants.</bold> Eleven different single nucleotide variants, all located in conserved splice consensus sites of introns 7 and 8, were identified in 17 families with vitreoretinopathy. In some cases, identical pathogenic variants have been found in different, unrelated families (<xref ref-type="table" rid="wagner.T.selected_vcan_pathogenic_varian">Table 2</xref>). In several individuals, it was shown that the pathogenic variants can lead to aberrant splice products and/or to quantitative changes of the naturally occurring splice variants lacking exon 8. No pathogenic exon variants have been found.</p>
          <table-wrap id="wagner.T.selected_vcan_pathogenic_varian" position="anchor" orientation="portrait">
            <label>Table 2. </label>
            <caption>
              <p>Selected <italic toggle="yes">VCAN</italic> Pathogenic Variants</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                  <th id="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Intron <break/>Location</th>
                  <th id="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1"># of Families w/Pathogenic Variant</th>
                  <th id="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference</th>
                  <th id="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.9265+1G&#x0003e;A<hr/></td>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_2" rowspan="3" valign="middle" align="left" colspan="1">Intron 8 splice donor site<hr/></td>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1<hr/></td>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="wagner.REF.rothschild.2013a.805">Rothschild et al [2013a]</xref>
                    <hr/>
                  </td>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_5" rowspan="11" valign="middle" align="left" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_004385.4">NM_004385.4</ext-link>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_004376.2">NP_004376.2</ext-link></td>
                </tr>
                <tr>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.9265+1G&#x0003e;T<hr/></td>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_3" valign="middle" colspan="1" align="left" rowspan="1">2<hr/></td>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="wagner.REF.kloeckenergruissem.2006.350">Kloeckener-Gruissem et al [2006]</xref>, <xref ref-type="bibr" rid="wagner.REF.meredith.2007.655">Meredith et al [2007]</xref>, <xref ref-type="bibr" rid="wagner.REF.ronan.2009.1511">Ronan et al [2009]</xref><hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.9265+2T&#x0003e;A<hr/></td>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_3" valign="middle" colspan="1" align="left" rowspan="1">2<hr/></td>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="wagner.REF.kloeckenergruissem.2013.352">Kloeckener-Gruissem et al [2013]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4004-1G&#x0003e;A<hr/></td>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_2" rowspan="8" valign="middle" align="left" colspan="1">IVS 7 splice acceptor site</td>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">1<hr/></td>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="wagner.REF.mukhopadhyay.2006.3565">Mukhopadhyay et al [2006]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4004-1G&#x0003e;C<hr/></td>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_3" valign="middle" colspan="1" align="left" rowspan="1">1<hr/></td>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="wagner.REF.kloeckenergruissem.2013.352">Kloeckener-Gruissem et al [2013]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4004-1G&#x0003e;T<hr/></td>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_3" valign="middle" colspan="1" align="left" rowspan="1">1<hr/></td>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="wagner.REF.chen.2013.2186">Chen et al [2013]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4004-2A&#x0003e;G<hr/></td>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_3" valign="middle" colspan="1" align="left" rowspan="1">1<hr/></td>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="wagner.REF.miyamoto.2005.2726">Miyamoto et al [2005]</xref>, <xref ref-type="bibr" rid="wagner.REF.br_zin.2011.1669">Br&#x000e9;zin et al [2011]</xref><hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4004-2A&#x0003e;T<hr/></td>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_3" valign="middle" colspan="1" align="left" rowspan="1">1<hr/></td>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="wagner.REF.br_zin.2011.1669">Br&#x000e9;zin et al [2011]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4004-5T&#x0003e;C<hr/></td>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_3" valign="middle" colspan="1" align="left" rowspan="1">4<hr/></td>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="wagner.REF.mukhopadhyay.2006.3565">Mukhopadhyay et al [2006]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4004-5T&#x0003e;A<hr/></td>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_3" valign="middle" colspan="1" align="left" rowspan="1">2<hr/></td>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="wagner.REF.mukhopadhyay.2006.3565">Mukhopadhyay et al [2006]</xref>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4004-6T&#x0003e;A</td>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_3" valign="middle" colspan="1" align="left" rowspan="1">2</td>
                  <td headers="hd_h_wagner.T.selected_vcan_pathogenic_varian_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="wagner.REF.rothschild.2013b.2040">Rothschild et al [2013b]</xref>
                  </td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold> The extracellular matrix proteoglycan (chondroitin sulfate proteoglycan type 2), also named versican core protein, is found in many different tissues in the human body, including the eye [<xref ref-type="bibr" rid="wagner.REF.white.2000.130">White &#x00026; Bruzzone 2000</xref>]. Four naturally occurring protein isoforms accumulate tissue-specifically. They are products of alternative splicing of exons 7 and 8 (see <xref ref-type="fig" rid="wagner.F1">Figure 1</xref>). A central domain of the protein, encoded by both exons 7 and 8, carries glycosaminoglycan (GAG) residue modifications, which may be involved in preventing collagen fibrils from adhering, thus ensuring the gel-like properties of the vitreous content. Versican appears to have a central role in the outflow resistance through the trabecular meshwork, and splicing variant patterns in the trabecular meshwork extracellular matrix are altered in glaucoma [<xref ref-type="bibr" rid="wagner.REF.keller.2007.1164">Keller et al 2007</xref>, <xref ref-type="bibr" rid="wagner.REF.keller.2011.5049">Keller et al 2011</xref>].</p>
          <p><bold>Abnormal gene product.</bold> Pathogenic variants in splice consensus sites result in skipping of exon 8 and in the production of aberrant splice products [<xref ref-type="bibr" rid="wagner.REF.miyamoto.2005.2726">Miyamoto et al 2005</xref>, <xref ref-type="bibr" rid="wagner.REF.kloeckenergruissem.2006.350">Kloeckener-Gruissem et al 2006</xref>, <xref ref-type="bibr" rid="wagner.REF.mukhopadhyay.2006.3565">Mukhopadhyay et al 2006</xref>]. One consequence is increased accumulation of splice variant V2 (no exon 8; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_001157570.1">NP_001157570.1</ext-link>) and V3 (no exon 7 and 8; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_001119808.1">NP_001119808.1</ext-link>) [<xref ref-type="bibr" rid="wagner.REF.mukhopadhyay.2006.3565">Mukhopadhyay et al 2006</xref>] and most likely their respective protein isoforms. This may result in severe reduction of GAG modification, which will render the physical properties of the vitreous, leading to a process of premature liquefaction.</p>
        </sec>
      </sec>
      <sec id="wagner.References">
        <title>References</title>
        <sec id="wagner.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="wagner.Literature_Cited.reflist0">
            <ref id="wagner.REF.audo.2008.2082">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Audo</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michaelides</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robson</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hawlina</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vaclavik</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandbach</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neveu</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hogg</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hunt</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Webster</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holder</surname>
                    <given-names>GE</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Phenotypic variation in enhanced S-cone syndrome.</article-title>
                <source>Invest Ophthalmol Vis Sci</source>
                <volume>49</volume>
                <fpage>2082</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">18436841</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.bennett.1990.1125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bennett</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Folk</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimura</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russell</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stone</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raphtis</surname>
                    <given-names>EM</given-names>
                  </name>
                </person-group>
                <year>1990</year>
                <article-title>Autosomal dominant neovascular inflammatory vitreoretinopathy.</article-title>
                <source>Ophthalmology</source>
                <volume>97</volume>
                <fpage>1125</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">2234842</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.br_zin.2011.1669">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Br&#x000e9;zin</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nedelec</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barjol</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rothschild</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delpech</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valleix</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>A new VCAN/versican splice acceptor site mutation in a French Wagner family associated with vascular and inflammatory ocular features.</article-title>
                <source>Mol Vis.</source>
                <year>2011</year>
                <volume>17</volume>
                <fpage>1669</fpage>
                <lpage>78</lpage>
                <pub-id pub-id-type="pmid">21738396</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.chen.2013.2186">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheng</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pan</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rong</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lai</surname>
                    <given-names>TY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vollrath</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pang</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Targeted sequencing of 179 genes associated with hereditary retinal dystrophies and 10 candidate genes identifies novel and known mutations in patients with various retinal diseases.</article-title>
                <source>Invest Ophthalmol Vis Sci.</source>
                <year>2013</year>
                <volume>54</volume>
                <fpage>2186</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">23462753</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.du.2013.701">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Du</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yee</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Roles of versican in cancer biology--tumorigenesis, progression and metastasis.</article-title>
                <source>Histol Histopathol</source>
                <volume>28</volume>
                <fpage>701</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">23519970</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.edwards.2008.460">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Edwards</surname>
                    <given-names>AO</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Clinical features of the congenital vitreoretinopathies</article-title>
                <source>Pediatr Dermatol</source>
                <volume>25</volume>
                <fpage>460</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">18789088</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.graemiger.1995.1830">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Graemiger</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niemeyer</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneeberger</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messmer</surname>
                    <given-names>EP</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Wagner vitreoretinal degeneration. Follow-up of the original pedigree.</article-title>
                <source>Ophthalmology</source>
                <volume>102</volume>
                <fpage>1830</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9098284</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.gupta.2002.203">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gupta</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leonard</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Damji</surname>
                    <given-names>KF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bulman</surname>
                    <given-names>DE</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>A frame shift mutation in a tissue-specific alternatively spliced exon of collagen 2A1 in Wagner's vitreoretinal degeneration.</article-title>
                <source>Am J Ophthalmol</source>
                <volume>133</volume>
                <fpage>203</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">11812423</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.haider.2000.127">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Haider</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacobson</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cideciyan</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swiderski</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Streb</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Searby</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beck</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hockey</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanna</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duhl</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carmi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bennett</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weleber</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fishman</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wright</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stone</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheffield</surname>
                    <given-names>VC</given-names>
                  </name>
                </person-group>
                <article-title>Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate.</article-title>
                <source>Nat Genet.</source>
                <year>2000</year>
                <volume>24</volume>
                <fpage>127</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">10655056</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.jansen.1962.458">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jansen</surname>
                    <given-names>LM</given-names>
                  </name>
                </person-group>
                <year>1962</year>
                <article-title>Degeneratio hyaloideo-retinalis herditaria.</article-title>
                <source>Ophthalmologica.</source>
                <volume>144</volume>
                <fpage>458</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">14041873</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.jewsbury.2014.291">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jewsbury</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fry</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watts</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nas</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Congenital glaucoma in Wagner syndrome.</article-title>
                <source>J AAPOS</source>
                <volume>18</volume>
                <fpage>291</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">24767812</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.keller.2007.1164">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Keller</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelley</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Acott</surname>
                    <given-names>TS</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Extracellular matrix gene alternative splicing by trabecular meshwork cells in response to mechanical stretching.</article-title>
                <source>Invest Ophthalmol Vis Sci</source>
                <volume>48</volume>
                <fpage>1164</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">17325160</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.keller.2011.5049">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Keller</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bradley</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vranka</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Acott</surname>
                    <given-names>TS</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Segmental versican expression in the trabecular meshwork and involvement in outflow facility.</article-title>
                <source>Invest Ophthalmol Vis Sci</source>
                <volume>52</volume>
                <fpage>5049</fpage>
                <lpage>57</lpage>
                <pub-id pub-id-type="pmid">21596823</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.keren.2007.1514">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Keren</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>OT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000e9;rard-Blanluet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Br&#x000e9;mond-Gignac</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elmaleh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Titomanlio</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delezoide</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Passos-Bueno</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verloes</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>CNS malformations in Knobloch syndrome with splice mutation in COL18A1 gene.</article-title>
                <source>Am J Med Genet A</source>
                <volume>143A</volume>
                <fpage>1514</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17546652</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.kloeckenergruissem.2006.350">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kloeckener-Gruissem</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartholdi</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abdou</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimmermann</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berger</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Identification of the genetic defect in the original Wagner syndrome family.</article-title>
                <source>Mol Vis</source>
                <volume>12</volume>
                <fpage>350</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">16636652</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.kloeckenergruissem.2013.352">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kloeckener-Gruissem</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neidhardt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magyar</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plauchu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zech</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morl&#x000e9;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmer-Smith</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macdonald</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nas</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fry</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berger</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <article-title>Novel VCAN mutations and evidence for unbalanced alternative splicing in the pathogenesis of Wagner syndrome.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2013</year>
                <volume>21</volume>
                <fpage>352</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">22739342</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.lemire.1999.1630">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lemire</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braun</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maurel</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplan</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwartz</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wight</surname>
                    <given-names>TN</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Versican/PG-M isoforms in vascular smooth muscle cells.</article-title>
                <source>Arterioscler Thromb Vasc Biol</source>
                <volume>19</volume>
                <fpage>1630</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">10397680</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.mahajan.2012.e1003001">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mahajan</surname>
                    <given-names>VB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skeie</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bassuk</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fingert</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braun</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daggett</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Folk</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheffield</surname>
                    <given-names>VC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stone</surname>
                    <given-names>EM</given-names>
                  </name>
                </person-group>
                <article-title>Calpain-5 mutations cause autoimmune uveitis, retinal neovascularization, and photoreceptor degeneration.</article-title>
                <source>PLoS Genet.</source>
                <year>2012</year>
                <volume>8</volume>
                <fpage>e1003001</fpage>
                <pub-id pub-id-type="pmid">23055945</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.menzel.2004.77">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Menzel</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bekkeheien</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reymond</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukai</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boye</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kosztolanyi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aftimos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deutsch</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olsen</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antonarakis</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guipponi</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Knobloch syndrome: novel mutations in COL18A1, evidence for genetic heterogeneity, and a functionally impaired polymorphism in endostatin.</article-title>
                <source>Hum Mutat</source>
                <volume>23</volume>
                <fpage>77</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">14695535</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.meredith.2007.655">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Meredith</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richards</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poulson</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snead</surname>
                    <given-names>MP</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Clinical characterisation and molecular analysis of Wagner syndrome.</article-title>
                <source>Br J Ophthalmol</source>
                <volume>91</volume>
                <fpage>655</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17035272</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.miyamoto.2005.2726">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Miyamoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inoue</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakamoto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kudo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naito</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mikawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mikawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isashiki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osabe</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shinohara</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shiota</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Itakura</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Identification of a novel splice site mutation of the CSPG2 gene in a Japanese family with Wagner syndrome.</article-title>
                <source>Invest Ophthalmol Vis Sci</source>
                <volume>46</volume>
                <fpage>2726</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">16043844</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.mukhopadhyay.2006.3565">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mukhopadhyay</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nikopoulos</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maugeri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Brouwer</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Nouhuys</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boon</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perveen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zegers</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wittebol-Post</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Biesen</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Velde-Visser</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoyng</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cremers</surname>
                    <given-names>FP</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Erosive vitreoretinopathy and wagner disease are caused by intronic mutations in CSPG2/Versican that result in an imbalance of splice variants.</article-title>
                <source>Invest Ophthalmol Vis Sci</source>
                <volume>47</volume>
                <fpage>3565</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">16877430</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.oh.2006.940">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oh</surname>
                    <given-names>KT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vallar</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Central cone dysfunction in autosomal dominant vitreoretino choroidopathy (ADVIRC).</article-title>
                <source>Am J Ophthalmol</source>
                <volume>141</volume>
                <fpage>940</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">16678511</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.ronan.2009.1511">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ronan</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tran-Viet</surname>
                    <given-names>KN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burner</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Metlapally</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toth</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>TL</given-names>
                  </name>
                </person-group>
                <article-title>Mutational hot spot potential of a novel base pair mutation of the CSPG2 gene in a family with Wagner syndrome.</article-title>
                <source>Arch Ophthalmol</source>
                <year>2009</year>
                <volume>127</volume>
                <fpage>1511</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19901218</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.rothschild.2013a.805">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rothschild</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Audo</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nedelec</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghiotti</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Br&#x000e9;zin</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valleix</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>De novo splice mutation in the versican gene in a family with Wagner syndrome.</article-title>
                <source>JAMA Ophthalmol.</source>
                <year>2013a</year>
                <volume>131</volume>
                <fpage>805</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">23571384</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.rothschild.2013b.2040">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rothschild</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Br&#x000e9;zin</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nedelec</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burin des Roziers</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghiotti</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orhant</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boimard</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valleix</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>A family with Wagner syndrome with uveitis and a new versican mutation.</article-title>
                <source>Mol Vis.</source>
                <year>2013b</year>
                <volume>19</volume>
                <fpage>2040</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">24174867</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.rothschild.2011.1555">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rothschild</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000e9;vy</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savignoni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lumbroso-Le Rouic</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aerts</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gauthier-Villars</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Esteve</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bours</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desjardins</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doz</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000e9;vy-Gabriel</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Familial retinoblastoma: fundus screening schedule impact and guideline proposal. A retrospective study.</article-title>
                <source>Eye (Lond)</source>
                <year>2011</year>
                <volume>25</volume>
                <fpage>1555</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">21921957</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.wagner.1938.840">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>1938</year>
                <article-title>Ein bisher unbekanntes Erbleiden des Auges, beobachtet im Kanton Zurich 1.</article-title>
                <source>Klinische Monatsbl&#x000e4;tter f&#x000fc;r Augenheilkunde</source>
                <volume>100</volume>
                <fpage>840</fpage>
                <lpage>57</lpage>
              </element-citation>
            </ref>
            <ref id="wagner.REF.wight.2014.152">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wight</surname>
                    <given-names>TN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kang</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merrilees</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <article-title>Versican and the control of inflammation.</article-title>
                <source>Matrix Biol</source>
                <year>2014</year>
                <volume>35</volume>
                <fpage>152</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">24513039</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.white.2000.130">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruzzone</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Intercellular communication in the eye: clarifying the need for connexin diversity.</article-title>
                <source>Brain Res Brain Res Rev</source>
                <volume>32</volume>
                <fpage>130</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">10751662</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.yao.1994.213">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yao</surname>
                    <given-names>LY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moody</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000f6;nherr</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wight</surname>
                    <given-names>TN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandell</surname>
                    <given-names>LJ</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization and immunohistochemistry.</article-title>
                <source>Matrix Biol</source>
                <volume>14</volume>
                <fpage>213</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">7921538</pub-id>
              </element-citation>
            </ref>
            <ref id="wagner.REF.zech.1999.387">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zech</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morl&#x000e9;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alloisio</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bozon</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonnet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milazzo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grange</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trepsat</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Godet</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plauchu</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Wagner vitreoretinal degeneration with genetic linkage refinement on chromosome 5q13-q14.</article-title>
                <source>Graefes Arch Clin Exp Ophthalmol</source>
                <volume>237</volume>
                <fpage>387</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">10333105</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="wagner.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="wagner.Acknowledgments">
          <title>Acknowledgments</title>
          <p>The authors would like to thank Drs Wolfgang Berger and John Neidhardt for critical reading of the manuscript.</p>
        </sec>
        <sec id="wagner.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>7 January 2016 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>16 August 2012 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>3 February 2009 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>18 April 2008 (bkg) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="wagner.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Vitreoretinopathy-associated pathogenic variants in <italic toggle="yes">VCAN</italic> and their effects on naturally occurring splice variants and protein isoforms. Under normal conditions, differential splicing leads to four transcript variants and protein isoforms V0, V1, V2, or V3, depending on the presence of exon 7 (red) and/or exon 8 (green). Attachment of glycosaminoglycan residues (GAGs; black vertical lines) modifies the protein to function in water inclusion. Pathogenic variants (black single-line vertical arrows pointing downward) lead to skipping of exon 8 and yielding increased amounts of variants V2 and V3. The effects of the variants on isoform expression (decrease or increase) are displayed by vertical turquoise-filled arrows. An imbalanced quantitative ratio of these variants is a result of the pathogenic variants. Schematic lines are not drawn to scale. Exon sizes are given in nucleotides (nt). Protein isoform length is given by number of amino acid (aa) residues beneath each isoform. c.4004 and c.9265 are the first and last nucleotide of exon 8.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="wagner-Image001" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
